Sarcoma, Alveolar Soft Part
A variety of rare sarcoma having a reticulated fibrous stroma enclosing groups of sarcoma cells, which resemble epithelial cells and are enclosed in alveoli walled with connective tissue. It is a rare tumor, usually occurring between 15 and 35 years of age. It appears in the muscles of the extremities in adults and most commonly in the head and neck regions of children. Though slow-growing, it commonly metastasizes to the lungs, brain, bones, and lymph nodes. (DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1365)
Drugs by status
Approved for this indication (1)
Phase 3 trials (5)
Phase 2 trials (11)
Phase 1 trials (5)
Organizations
Organization Involved with Phase 3 Indications (2)
Organization Involved with Phase 2 Indications (23)
- Bristol-Myers Squibb
- Merck
- Pfizer
- AEterna Zentaris
- ArQule
- University of London
- Cornell University
- Katholieke Universiteit Leuven
- Oregon Health and Science University
- Sarcoma Alliance for Research through Collaboration
- Seoul National University
- University of Miami
- University of Michigan
- Wake Forest University
- Yonsei University
- University of Ulsan
- Royal Marsden Hospital NHS Trust
- European Organisation for Research and Treatment of Cancer
- University of Texas at Houston
- Sungkyunkwan University
- Memorial Sloan-Kettering Cancer Center
- Genor BioPharma Co., Ltd.
- Chinese Academy of Medical Sciences
Organization Involved with Phase 1 Indications (5)